SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBCHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SBC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $530.32M
- P/E (TTM)
- 10.14
- Forward P/E
- 8.99
- EPS (TTM)
- $0.51
- Dividend yield
- None
- 52-week range
- 2.78 – 7.39
- Day range
- 5.03 – 5.53
- Volume / Avg
- 377.59K / 256.99K
- Beta
- —
- Shares outstanding
- 102.58M
52-week range
SBC stock today
SBC Medical Group (SBC) closed at $5.17 on Nov 20, down 7.68% (-$0.43), versus the S&P 500's 3.70% decline. At this level, SBC sits in the middle of its 52-week range of $2.78 to $7.39: 30.0% below the high, set on Nov 13, 2026 and 86.0% above the low. SBC is up 20.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 56.2%.
At 10.1x trailing earnings, SBC Medical Group trades below the peer-group median of 29.7x. Its forward P/E of 9.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About SBC Medical Group
Company profileSBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Dr. Yoshiyuki Aikawa
- Headquarters
- Irvine, CA
- Employees
- 863
- IPO year
- 2022
- Website
- sbc-holdings.com
Financial highlights
Full financialsIn fiscal 2025, SBC Medical Group generated $173.6 million in revenue, down 15.5% from fiscal 2024, the first decline in the 3 years shown. Net income was $51.0 million (+9.4% year over year), for a net margin of 29.4% versus a median of 21.5% in the prior 2 years. Gross margin was 73.3% (down from 76.0%) and operating margin 38.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $173.61M | $205.42M | $193.54M |
| Growth | -15.48% | +6.13% | — |
| Net income | $50.99M | $46.61M | $39.37M |
| EPS (diluted) | $0.50 | $0.48 | $0.42 |
Analyst forecast
ForecastConsensus (3 analysts)
strong_buy
Avg. price target
$10.00+93.42%
- Strong buy 1
- Buy 2
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 13, 2026
- EPS actual vs est.
- $0.15 vs $0.11
- Surprise
- +36.36%
SBC news
All SBC news- SBC Medical Q3 Results Shows Revenue And EBITDA Growth; Shares Retreat 12%NasdaqSBC, BRK.A
- SBC Medical Group Holdings legt Finanzergebnisse für das dritte Quartal 2026 vorBusiness Wire
- SBC Medical Group Holdings publie ses résultats financiers pour le troisième trimestre 2026Business Wire
- Samenvatting: SBC Medical Group Holdings presenteert financiële resultaten over derde kwartaal van 2026Business Wire
- Resumen: SBC Medical Group Holdings presenta los resultados financieros correspondientes al tercer trimestre de 2026Business Wire
- Riassunto: SBC Medical Group Holdings annuncia i risultati finanziari del terzo trimestre 2026Business Wire
- Why SBC Medical Stock Skyrocketed on FridayNasdaq
- SBC Medical (SBC) Q3 2026 Earnings Call TranscriptNasdaq
SBC Medical Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SRTAStrata Critical Medical Inc. Class A | 4.56 | -5.59% | $407.30M | vs SBC |
| PIIIP3 Health Partners Inc. Class A | 1.69 | -9.14% | $350.24M | vs SBC |
| OMDAOmada Health Inc. | 11.87 | -5.04% | $736.39M | vs SBC |
| STLNStarling Oncology Inc. | 3.00 | -5.66% | $305.97M | vs SBC |
| AUNAAuna SA Class A | 3.66 | -6.15% | $271.05M | vs SBC |
| AHCOAdaptHealth Corp. | 7.20 | -0.69% | $982.98M | vs SBC |
| LFMDLifeMD Inc. | 1.45 | -9.40% | $69.84M | vs SBC |
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs SBC |
Indexes, lists and sector
SBC Medical Group stock FAQ
What is SBC Medical Group's stock price today?
SBC last traded at $5.17 as of Nov 20, 4:00 PM EST, down 7.68% on the day. Prices are delayed at least 15 minutes.
What is SBC's P/E ratio?
SBC trades at a trailing P/E ratio of 10.14 and a forward P/E of 8.99, compared with a median of 29.7 for its closest peers.
Who is SBC Medical Group's CEO?
Dr. Yoshiyuki Aikawa is the chief executive officer of SBC Medical Group Holdings Incorporated, which has about 863 employees.
What is the SBC 52-week high?
The 52-week high for SBC is $7.39 and the 52-week low is $2.78. The stock is currently 30.0% below its high.